Tempus AI, Inc.

TEM Healthcare Health Information Services

Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024.

Revenue
+23.1%
EPS
+82.2%
Free cash flow
+95.7%
Total debt
+8.44%

Quarter to September 2026, against a year earlier

76.26 5.83 +8.28%
Market cap
$12.9B
P/E
0.0×
Fwd P/E
−51.8×
Dividend yield
—
F-score
4/9
Altman Z
2.60
Beneish M
−1.25
Dividend safety
n/a

Tempus AI, Inc. (TEM) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Tempus AI, Inc. (TEM) trades at a P/B ratio of 25.5×. Over the past ten years it has ranged from 0.0× (June 2024) to 239× (November 2024); the current reading is higher than 38% of that period. That is above the Health Information Services industry median of 1.9× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 20.9× (70.84%)
FY2024 71.8× —
FY2023 0.0× —
FY2022 0.0× —

Quarterly newest first

Period P/B ratio Change
Sep 2026 29.7× 26.68%
Jun 2026 23.4× 20.59%
Mar 2026 19.4× (7.25%)
Dec 2025 20.9× (24.67%)
11 more quarters

Against its own ten years

Low 0.0× High 239×
Ten-year median 30.7×
Current reading's percentile 38

P/B ratio against peers

Company P/B ratio
WAY Waystar Holding Corp. compare 1.4×
PRVA Privia Health Group, Inc. compare 3.5×
HQY HealthEquity, Inc. compare 4.3×
BTSG BrightSpring Health Services, Inc. compare 6.3×
DOCS Doximity, Inc. compare 6.4×
VEEV Veeva Systems Inc. compare 6.8×
HTFL Heartflow, Inc. compare 16.1×
TEM Tempus AI, Inc. 25.5×
HNGE Hinge Health Inc. compare 26.6×
Health Information Services industry median 1.9×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on TEM